Immuneering Corp (IMRX)
1.80
-0.14
(-7.22%)
USD |
NASDAQ |
Nov 15, 16:00
1.81
+0.01
(+0.56%)
After-Hours: 20:00
Immuneering Net Income (TTM): -56.07M for June 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
June 30, 2024 | -56.07M |
March 31, 2024 | -54.18M |
December 31, 2023 | -53.47M |
September 30, 2023 | -51.63M |
June 30, 2023 | -51.88M |
March 31, 2023 | -51.22M |
December 31, 2022 | -50.51M |
September 30, 2022 | -48.05M |
Date | Value |
---|---|
June 30, 2022 | -43.74M |
March 31, 2022 | -40.20M |
December 31, 2021 | -33.54M |
September 30, 2021 | -28.59M |
June 30, 2021 | -24.45M |
March 31, 2021 | -20.07M |
December 31, 2020 | -17.04M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-56.07M
Minimum
Jun 2024
-17.04M
Maximum
Dec 2020
-41.64M
Average
-48.05M
Median
Sep 2022
Net Income (TTM) Benchmarks
Singular Genomics Systems Inc | -91.89M |
Biomarin Pharmaceutical Inc | 322.29M |
Integra Lifesciences Holdings Corp | -6.544M |
Eton Pharmaceuticals Inc | -6.687M |
Tenon Medical Inc | -13.87M |